Human Embryonic Stem Cell Study Uncovers Genetic Mutations in Federally-Approved Lines
Johns Hopkins’ Aravinda Chakravarti and Anirban Maitra, and Mahendra Rao at the National Institute on Aging discuss the use of high-resolution methods for quality control of cell linesScientists led by Dr. Aravinda Chakravarti, director of the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins Medical Center and Mahendra Rao, head of the Stem Cell Group in the Laboratory of Neuroscience at the National Institute on Aging, report that they have uncovered mutations in federally approved embryonic stem cell lines that have been cultured in the laboratory over extended periods of time. Identification of genetic abnormalities in these lines cast doubt on their safety and efficacy for therapeutic use and has many implications for biological studies on them.
“These mutations may be widespread in all kinds of cultured cells, but genetic changes are particularly important in embryonic stem cells,” said Chakravarti.
Read more
|
Copy Number